Personalis Genomics (PSNL) Cash Funds per Single Share

Corporate emblem and logo of Personalis, Inc. (PSNL)

Personalis, Inc. develops precision oncology tests in its laboratories, leveraging demand from pharmaceutical companies. Free cash flow per share illustrates the connection between this production and cloud data storage, where the parameter value equals 1.76. The reliance on IT infrastructure is offset by the humanitarian status of the business, which guarantees stable development regardless of geopolitical sanctions or trade barriers.

Personalis Inc (PSNL): Cash Funds per Share from 07/04/2022 to 11/20/2026

Analytical breakdowns for Personalis, Inc.

- market price and analyst price targets:
- cash position and cash flow details:
General company analysis:Personalis Corp - PSNL
Manufactured product of Personalis

Personalis, Inc. (PSNL) faces risks of liquidity depletion and reliance on equity offerings due to high test promotion costs coupled with slow insurance coverage adoption. The current value of 1.76 reflects the net cash per share, allowing the cash per share metric to assess the business's protection against cash flow gaps and the risk of freezing excess capital.

Key competitors

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|Erasca (ERAS) - Cash Funds per Share|DCTH - Cash Funds Calculated per Share|YMAB (Y-mAbs Corp) - Cash per Share|Cash per Single Share Aura Biosciences (AURA)|Cash Funds per Share Candel Therapeutics Inc. (CADL)|Cash per Single Share Accuray, Inc. ARAY|Cash Funds per Share sellaslifesciences.com SLS|Amount of Cash per Share ACTU|CTOR - Cash Funds per Share|Cash Funds Calculated per Share tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Cash Funds per Share|FATE: Cash Calculated per Single Share|WHWK (Aadi Bioscience, Inc.) - Cash per Share|TCRX (TScan Therapeutics) - Cash Calculated per Single Share|Cash Funds per Share Champions Oncology (CSBR)|Cash Funds Calculated per Share XBiotech USA|Cash Funds per Share CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Cash on Hand per Share|RADX - Cash Funds per Share|ARTV - Cash per Share|Adlai Nortye Ltd (ANL) - Cash Funds per Share|Veru Pharma - Amount of Cash per Share|Cash Funds per Share Tempest Therapeutics Corp|Cash Funds per Single Share XLO (Xilio Therapeutics, Inc.)|Cash per Share RENB|MURA (Mural Oncology) - Amount of Cash per Share|Cash per Share KAPA (Kairos Pharma Ltd)|OKUR: Cash Funds per Single Share|GDTC: Cash per Single Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com